Traphaco JSC (HOSE:TRA)
Vietnam · Delayed Price · Currency is VND 76,400
+1,400 (1.87%)
At close: Apr 24, 2026
Traphaco JSC Revenue
In the year 2025, Traphaco JSC had annual revenue of 2.66T VND with 13.21% growth. Traphaco JSC had revenue of 721.37B in the quarter ending December 31, 2025, with 17.13% growth.
Revenue
2.66T
Revenue Growth
+13.21%
P/S Ratio
1.19
Revenue / Employee
1.59B
Employees
1,670
Market Cap
3.17T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.66T | 309.99B | 13.21% |
| Dec 31, 2024 | 2.35T | 47.99B | 2.09% |
| Dec 31, 2023 | 2.30T | -99.68B | -4.16% |
| Dec 31, 2022 | 2.40T | 238.08B | 11.02% |
| Dec 31, 2021 | 2.16T | 251.97B | 13.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DHG Pharmaceutical JSC | 5.27T |
| Ha Tay Pharmaceutical JSC | 2.40T |
| Imexpharm | 2.39T |
| Domesco Medical Import - Export Joint-Stock | 2.12T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| OPC Pharmaceutical JSC | 1.12T |
| Vidipha Central Pharmaceutical JSC | 971.25B |